Prospective, non-randomized, multi-center study assessing the long term safety and efficacy of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected left main coronary artery disease.
- Clinical Endpoint: Target Lesion Failure at 12 months post-procedure
- Efficacy Endpoint: Angiographic success at 12 months post-procedure: Achievement of <20% final residual stenosis at target lesion (visual estimation) with TIMI 3 flow in main branch.
- Project Management
- Electronic Data Capture Management
- Data Management
- CEC activities
- Core Laboratory
- Safety Reporting
- Statistical Activities and Clinical Report
France, Germany, Italy, Poland, Switzerland and The Netherlands managed by CERC.
18 centers managed by CERC.